Prof. Dr. Michael Stark specializes in Obstetrics and Gynecology. His main interest is gynecological oncology.  He initiated the VIEZION project which combines targeted chemotherapy, PIF, immunology and stem-cell therapy for improving post-surgical oncological treatment. He modified operations like the vaginal and abdominal hysterectomy and Cesarean Section and developed the concept of single-entry natural orifice surgery.

In the years 2002-2010 he was the chairman of all the gynecological departments of the HELIOS hospital group in Germany and Austria.

Since 2004 he has been the President of the New European Surgical Academy (NESA), an international inter-disciplinary surgical organization with members in 57 countries.

In the years 2011-2013 he was the scientific advisor of the USP hospital in Mallorca, Spain.

Between 2012-2015 he was the scientific director of the new European surgical robotic system (TELELAP) at SOFAR company in Milan, Italy.

Between 2016-2019 he was the scientific consultant of the ELSAN 123 hospitals in France

In 2011, Prof. Stark was nominated as the Medico Del Anno (Doctor of the Year) in Italy, and is an Honorary Member of the French, Polish, Russian, Serbian-Austrian and Italian Gynecological Associations. These days he is professor for Robotic Surgery and Evidence Based Medicine at the university of Adana, scientist at the Charite University Hospital in Berlin, adjunct professor at the MIPT university in Moscow and Honorary Professor at the University of Chisinau.

He was visiting Professor at the Universities of Toronto, Moscow, Beijing, Milan, Adana, Uppsala and the Weill-Cornell University hospital in New York.

Since 2019 he is the vice president of the Chinese Perinatology association.